Progress in classical Hodgkin lymphoma treatment with antibodies against programmed death 1 and its&nbsp;ligand

doi:10.3760/cma.j.issn.1673-4211.2018.05.005

PDF(694 KB)

International Journal of Biologicals ›› 2018, Vol. 41 ›› Issue (5) : 230-234. DOI: 10.3760/cma.j.issn.1673-4211.2018.05.005

Progress in classical Hodgkin lymphoma treatment with antibodies against programmed death 1 and its ligand

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 41(5): 230-234 https://doi.org/10.3760/cma.j.issn.1673-4211.2018.05.005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(694 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export